NCT00907374View on ClinicalTrials.gov

Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Microalbuminuria
Interventions
DRUG

benazepril

benazepril 10 mg orally once daily

DRUG

benazepril

40-80 mg benazepril plus 25-100 mg losartan orally once or twice daily

Trial Locations (1)

90059

Charles Drew University, Los Angeles

All Listed Sponsors
lead

Charles Drew University of Medicine and Science

OTHER

NCT00907374 - Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria | Biotech Hunter | Biotech Hunter